4U2W image
Deposition Date 2014-07-18
Release Date 2015-01-14
Last Version Date 2024-10-09
Entry Detail
PDB ID:
4U2W
Title:
Atomic resolution crystal structure of HV-BBI protease inhibitor from amphibian skin in complex with bovine trypsin
Biological Source:
Source Organism:
Odorrana versabilis (Taxon ID: 326940)
Bos taurus (Taxon ID: 9913)
Method Details:
Experimental Method:
Resolution:
1.00 Å
R-Value Free:
0.10
R-Value Work:
0.09
R-Value Observed:
0.09
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Cationic trypsin
Gene (Uniprot):PRSS1
Chain IDs:B (auth: A)
Chain Length:223
Number of Molecules:1
Biological Source:Bos taurus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Bowman-Birk trypsin inhibitor
Gene (Uniprot):bbi
Chain IDs:A (auth: B)
Chain Length:16
Number of Molecules:1
Biological Source:Odorrana versabilis
Primary Citation
Atomic resolution crystal structure of HV-BBI protease inhibitor from amphibian skin in complex with bovine trypsin.
Proteins 83 582 589 (2015)
PMID: 25546528 DOI: 10.1002/prot.24750

Abstact

Protease inhibitors of the Bowman-Birk (BBI) family are commonly found in plants and animals where they play a protective role against invading pathogens. Here, we report an atomic resolution (1Å) crystal structure of a peptide inhibitor isolated from a skin secretion of a Chinese bamboo odorous frog Huia versabilis (HV-BBI) in complex with trypsin. HV-BBI shares significant similarities in sequence with a previously described inhibitor from a diskless-fingered odorous frog Odorrana graham (ORB). However, the latter is characterized by more than a 16,000 fold higher Ki against trypsin than HV-BBI. Comparative analysis of trypsin cocrystal structures of HV-BBI and ORB and additionally that of Sunflower Trypsin Inhibitor (SFTI-1) together with accessory information on the affinities of inhibitor variants allowed us to pinpoint the inhibitor moiety responsible for the observed large difference in activity and also to define the extent of modifications permissible within the common protease-binding loop scaffold of BBI inhibitors. We suggest that modifications outside of the inhibitory loop permit the evolution of specificity toward different enzymes characterized by trypsin-like specificity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures